Hiroaki Mitsuya
National Institutes of Health(US)AIDS United(US)National Institute of Technology, Kumamoto College(JP)National Center for Global Health and Medicine(JP)Kumamoto University Hospital(JP)Center for Global Health(US)National Cancer Institute(MY)National Cancer Institute(US)Municipal Hirakata City Hospital(JP)Ekaterinburg Research Institute of Viral Infections(RU)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research, T-cell and Retrovirus Studies
Most-Cited Works
- → 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.(1985)1,846 cited
- → Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.(1986)1,347 cited
- → Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development(2020)1,161 cited
- → Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.(1986)1,038 cited
- → ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX(1986)804 cited
- → Molecular Targets for AIDS Therapy